Adam S. Grossman, President and CEO at ADMA BIOLOGICS, INC. (ADMA), sold 21,000 shares at $16.08 ($338K) on 2026-02-17, disclosed to the SEC on 2026-02-17.
Open-market sale of $338k ADMA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.08 | 6,000 | $96K | 28.6% |
| 2 | $16.08 | 15,000 | $241K | 71.4% |
| Total | $16.08 avg | 21,000 | $338K | 100% |
| Filing → |
| ADMA | SELL | 2025-11-21 | $336K | — | Filing → |
| ADMA | SELL | 2025-10-24 | $336K | — | Filing → |
| ADMA | SELL | 2025-09-16 | $581K | — | Filing → |